Stay updated on Immunotherapy Combo in Untreated Stage 3 NSCLC Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy Combo in Untreated Stage 3 NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy Combo in Untreated Stage 3 NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page’s footer revision label has been updated to v3.5.3, indicating a minor update to the ClinicalTrials.gov interface/versioning rather than a change to the trial record content.
    Difference
    0.0%
    Check dated 2026-04-25T17:37:07.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    A new revision v3.5.2 was added and the previous revision v3.5.0 was removed.
    Difference
    0.0%
    Check dated 2026-04-18T13:13:34.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    41 days ago
    Change Detected
    Summary
    The history now lists Revision: v3.5.0 as the latest entry, replacing Revision: v3.4.3. This appears to be a minor versioning update rather than a change to study content.
    Difference
    0.0%
    Check dated 2026-03-20T20:07:36.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The page now shows a new site revision label (v3.4.3) replacing the previous revision (v3.4.2).
    Difference
    0.0%
    Check dated 2026-03-06T18:02:09.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and Revision: v3.4.1 was removed from the page footer's version information. This is a minor UI/versioning update with no impact on content or trial data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T12:32:17.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    A minor revision update is recorded: v3.4.1 was added and v3.4.0 was removed. This does not affect study data, eligibility criteria, results, or user-facing features.
    Difference
    0.0%
    Check dated 2026-02-05T19:06:31.000Z thumbnail image

Stay in the know with updates to Immunotherapy Combo in Untreated Stage 3 NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy Combo in Untreated Stage 3 NSCLC Clinical Trial page.